Trevena, Inc.

Trevena, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Trevena, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Trevena, Inc..
Log in to see more information.
Trevena, Inc. is a biopharmaceutical company, which focuses on the development and commercialization...
TRVN Fundamental Data by TradingView

News

StockNews.com Initiates Coverage on Trevena (NASDAQ:TRVN)
StockNews.com Initiates Coverage on Trevena (NASDAQ:TRVN)

Ticker Report StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN - Get Free Report) in a report issued on Thursday. The brokerage set a "sell" rating on the biopharmaceutical company's stock...\n more…

Trevena (NASDAQ:TRVN) Now Covered by Analysts at StockNews.com
Trevena (NASDAQ:TRVN) Now Covered by Analysts at StockNews.com

Zolmax StockNews.com initiated coverage on shares of Trevena (NASDAQ:TRVN - Free Report) in a research note published on Wednesday morning. The brokerage issued a sell rating on the biopharmaceutical...\n more…

Trevena (NASDAQ:TRVN) Earns Sell Rating from Analysts at StockNews.com
Trevena (NASDAQ:TRVN) Earns Sell Rating from Analysts at StockNews.com

Ticker Report Equities research analysts at StockNews.com started coverage on shares of Trevena (NASDAQ:TRVN - Get Free Report) in a research note issued on Wednesday. The firm set a "sell" rating on the...\n more…

Trevena (NASDAQ:TRVN) Coverage Initiated by Analysts at StockNews.com
Trevena (NASDAQ:TRVN) Coverage Initiated by Analysts at StockNews.com

Zolmax StockNews.com started coverage on shares of Trevena (NASDAQ:TRVN - Free Report) in a research report released on Tuesday. The firm issued a sell rating on the biopharmaceutical company's...\n more…

Trevena (NASDAQ:TRVN) Coverage Initiated at StockNews.com
Trevena (NASDAQ:TRVN) Coverage Initiated at StockNews.com

Ticker Report Analysts at StockNews.com started coverage on shares of Trevena (NASDAQ:TRVN - Get Free Report) in a research report issued on Tuesday. The firm set a "sell" rating on the biopharmaceutical company's...\n more…

Financial Comparison: Trevena (NASDAQ:TRVN) and KALA BIO (NASDAQ:KALA)
Financial Comparison: Trevena (NASDAQ:TRVN) and KALA BIO (NASDAQ:KALA)

Ticker Report Trevena (NASDAQ:TRVN - Get Free Report) and KALA BIO (NASDAQ:KALA - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based...\n more…